The Global In Vitro Diagnostics Quality Control Market was valued at USD 815.3 million in 2016 and is projected to reach USD 1,077.6 million by 2025, growing at a CAGR of 3.2% from 2017 to 2025.
In vitro diagnostics (IVD) are tests that are used to detect diseases and infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
In vitro diagnostics include accessories and medical devices that are used to perform tests on samples, including blood, urine and tissue that has been taken from the human body in order to help detect infection, Diagnose a medical condition, prevent a disease and monitor drug therapies
In vitro diagnostics is an essential segment in the global healthcare industry. The marketplace is witnessing rapid growth fuelled by technological advancements, better diagnostic tools, improved treatment monitoring and increased availability of over-the-counter tests. IVDs add significant value to treatment processes and medical diagnoses, enhancing the well-being of the public.
Sample Infographics:
Whole blood-based products to account for the majority of the market share in 2025
Whole blood-based products are mainly focused on kits designed to diagnose blood related disorders such as Leukemia, Clotting disorders, Anemia, Chagas Disease, African sleeping sickness and Haemophilia. With increasing cases of leukemia, and other disorders (genetic and non-genetic), the demand of these products is also increasing.
Blood transfusion kits are widely used wherein the compatibility of the donor is tested with recipient’s blood type. Due to increased cases of disease spreads and deaths caused by blood transfusion, the healthcare sector is increasingly spending on such products to enhance the efficiency of the treatment and procedure.
In Vitro Diagnostics Quality Control Market to witness the fastest growth in the Hospitals segment
In Vitro Diagnostics provide solutions to healthcare professionals within the secondary care environment, ensuring that patients and clinicians have timely access to accurate test results. Hospitals are facing huge demand of diagnostic services all over the globe due to increasing prevalence of diseases, disorders, and unhealthy lifestyle changes.
Hospitals and healthcare centers utilize In Vitro Diagnostics products (tests) as well as diagnostic technologies and equipment. Developing nations are increasing investments on healthcare and related R&D, to enable the service providers to cater to the consumers in an efficient manner.
North America to account for the largest regional market size in 2025
North America dominated the global In Vitro Diagnostics (IVD) Quality Control market in 2016. This region is driven by growing demand for In Vitro Diagnostics products from the U.S.
The North American region is currently witnessing high growth with respect to healthcare service market due to a number of factors. Increase in geriatric population, prevalence of cancer cases and growing number of cancer patients and awareness amongst the population are some of the drivers of the North American healthcare market.
The demand of In Vitro Diagnostics (IVD) Quality Control products and services are therefore increasing simultaneously with Healthcare Services market. The IVD products are in huge demand due to advents in biotechnology and medical biotechnology sector
Bio-Rad Laboratories, Inc., Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Helena Laboratories, SeraCare Life Sciences, Inc., Ortho Clinical Diagnostics, Inc., Sun Diagnostics, LLC, SERO AS, Randox Laboratories Ltd., Siemens Healthineers, Technopath Clinical Diagnostics and Roche Diagnostics are some of the major players in the Global In Vitro Diagnostics Quality Control Market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the In Vitro Diagnostics Quality Control Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
Chapter 1 INTRODUCTION OF GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET 15
1.1 Market Overview 15
1.2 Market Segmentation 16
1.3 Assumptions 17
Chapter 2 EXECUTIVE SUMMARY 18
2.1 Overview of the Market 18
2.2 Global In Vitro Diagnostics (IVD) Quality Control Market, By Product - 2016 (USD Million) 19
2.3 Global In Vitro Diagnostics (IVD) Quality Control Market, By Application â€" 2016 (USD Million) 20
2.4 Global Pemetrexed Acid Market, By Geography (CAGR% 2017-2025) 21
Chapter 3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE 22
3.1 Data Mining 22
3.2 Secondary Research 22
3.3 Primary Research: 22
3.4 Subject Matter Expert Advice: 23
3.5 Quality Check 23
3.6 Final Review 23
3.7 Validation 24
3.8 Primary Interviews 24
3.9 Research Scope and Assumptions 25
3.10 List of data sources 25
Chapter 4 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET OUTLOOK 27
4.1 Market Dynamics 27
4.1.1 Market Drivers 28
4.1.2 Rise in number of Pathology labs in developing countries 28
4.1.3 Increment in the use of third party QC products 29
4.1.4 Market Restraints 31
4.1.5 Risks in reimbursement from IVD centers 31
4.1.6 High Cost of Quality Control 32
4.2 Porter’s Five Force Analysis 33
4.3 Regulatory Framework 34
4.3.1 Europe 34
4.3.2 U.S. (FDA) 37
Chapter 5 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY PRODUCT 40
5.1 Overview 41
5.2 Serum/Plasma-based Products 42
5.3 Whole Blood Based Products 43
5.4 Urine Based Products 44
5.5 Other Products 45
Chapter 6 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY APPLICATION 47
6.1 Overview 48
6.2 Immunochemistry 50
6.3 Clinical Chemistry 51
6.4 Hematology 52
6.5 Molecular Diagnostics 53
6.6 Coagulation/Hemastosis 54
6.7 Microbiology 55
6.8 Others 56
Chapter 7 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY END USER 57
7.1 Overview 58
7.2 Hospitals 60
7.3 Clinical laboratories 61
7.4 Research and Academic Institutes 62
7.5 Others 63
Chapter 8 GLOBAL IN VITRO DIAGNOSTICS (IVD) QUALITY CONTROL MARKET, BY GEOGRAPHY 64
8.1 Overview 65
8.2 North America 68
8.2.1 U.S. 73
8.2.2 Canada 76
8.2.3 Mexico 79
8.3 Europe 82
8.3.1 Germany 87
8.3.2 UK 90
8.3.3 France 93
8.3.4 Rest of Europe 96
8.4 Asia Pacific 99
8.4.1 China 104
8.4.2 Japan 107
8.4.3 India 110
8.4.4 Rest of Asia Pacific 113
8.5 Latin America 116
8.5.1 Brazil 121
8.5.2 Rest of Latin America 124
8.6 Middle East and Africa 127
Chapter 9 COMPETITIVE LANDSCAPE 130
9.1 Company Market Share 130
9.2 Key Trends 131
Chapter 10 COMPANY PROFILES 133
10.1 Bio-Rad Laboratories, Inc. 133
10.1.1 Company Overview 133
10.1.2 Bio-Rad Laboratories, Inc.: Key Facts 133
10.1.3 Financial Performance 134
10.1.4 Product Benchmarking 135
10.2 Abbott Laboratories Inc 142
10.2.1 Company Overview 142
10.2.2 Abbott Laboratories Inc: Key Facts 142
10.2.3 Financial Performance 143
10.2.4 Product Benchmarking 144
10.3 Thermo Fisher Scientific Inc. 145
10.3.1 Company Overview 145
10.3.2 Thermo Fisher Scientific Inc.: Key Facts 145
10.3.3 Financial Performance 146
10.3.4 Product Benchmarking 147
10.4 Helena Laboratories 149
10.4.1 Company Overview 149
10.4.2 Helena Laboratories: Key Facts 149
10.4.3 Product Benchmarking 150
10.5 SeraCare Life Sciences, Inc. 151
10.5.1 Company Overview 151
10.5.2 SeraCare Life Sciences, Inc.: Key Facts 151
10.5.3 Product Benchmarking 151
10.6 Ortho Clinical Diagnostics, Inc. 152
10.6.1 Company Overview 152
10.6.2 ITW Linx, Surge Protection: Key Facts 152
10.6.3 Product Benchmarking 153
10.7 Sun Diagnostics, LLC 154
10.7.1 Company overview 154
10.7.2 Sun Diagnostics, LLC: Key Facts 154
10.7.3 Product Benchmarking 155
10.8 SERO AS 156
10.8.1 Company Overview 156
10.8.2 SERO AS: Key Facts 156
10.8.3 Product Benchmarking 157
10.9 Randox Laboratories Ltd. 158
10.9.1 Company Overview 158
10.9.2 Randox Laboratories Ltd.: Key Facts 158
10.9.3 Product Benchmarking 159
10.10 Siemens Healthineers 160
10.10.1 Company Overview 160
10.10.2 Siemens Healthineers: Key Facts 160
10.10.3 Financial Performance 161
10.10.4 Product Benchmarking 162
10.11 Technopath Clinical Diagnostics 164
10.11.1 Company Overview 164
10.11.2 Technopath Clinical Diagnostics: Key Facts 164
10.11.3 Product Benchmarking 165
10.12 Roche Diagnostics 167
10.12.1 Company Overview 167
10.12.2 Roche Diagnostics: Key Facts 167
10.12.3 Financial Performance 168
10.12.4 Product Benchmarking 169
The Cloud-Based Automated Control System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Virtual Power Plant Control Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...
Market Overview
The North America Nuclear Medicine Market is poised for substantial growth between 2024 and 2034, driven by advancements in diagnostic imaging and therapeutic applications, rising prevalence of chronic diseases, and increasing adoption of nuclear medicine techniques. The...
Market Overview
The Global Nuclear Medicine Market is projected to experience significant growth from 2024 to 2034, driven by technological advancements in diagnostic imaging and the increasing demand for targeted radiopharmaceutical therapies. Valued at USD XX.XX billion in 2024, the m...
The Intelligent Content Risk Control Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Organic Pest Control Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The GxP Quality Management Systems Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...
The Microfluidic Control Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manu...